Bahl & Gaynor Inc. lessened its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,291 shares of the medical research company’s stock after selling 75 shares during the quarter. Bahl & […]
Intact Investment Management Inc. purchased a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 2,300 shares of the medical research company’s stock, valued at approximately $1,221,000. A number of other hedge funds also recently made changes to their positions in the stock. Alliance […]
Spinnaker Trust lessened its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 5.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 875 shares of the medical research company’s stock after selling 50 shares during the […]
Anchor Capital Advisors LLC lowered its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 34,167 shares of the medical research company’s stock after selling 1,762 shares during the quarter. […]
Private Wealth Partners LLC lifted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 1.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 85,131 shares of the medical research company’s stock after purchasing an additional 815 […]
Delta Investment Management LLC trimmed its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 15.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,934 shares of the medical research company’s stock after selling 551 shares during the period. Delta Investment […]
Truist Financial Corp decreased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 18.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 157,314 shares of the medical research company’s stock after selling 36,454 shares during […]
Abbrea Capital LLC decreased its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,962 shares of the medical research company’s stock after selling 47 shares during the period. Abbrea Capital LLC’s […]
Epic Trust Investment Advisors LLC lifted its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 31.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 928 shares of the medical research company’s stock after acquiring an additional 223 shares during the period. Epic […]
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price objective hoisted by HSBC from $660.00 to $670.00 in a report released on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the medical research company’s stock. HSBC’s price target indicates a potential upside of 17.12% from the company’s current price. Several […]
Israel Discount Bank of New York trimmed its stake in shares of BlackRock, Inc. (NYSE:BLK – Free Report) by 6.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 429 shares of the asset manager’s stock after selling 28 shares during the quarter. Israel […]
Abbrea Capital LLC purchased a new stake in shares of Equinix, Inc. (NASDAQ:EQIX – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 256 shares of the financial services provider’s stock, valued at approximately $206,000. Several other institutional investors also recently bought and […]